Loading…
Loading…
MONTSAME

Ulaanbaatar, June 3, 2026 /MONTSAME/. Preliminary results of the evaluation of Mongolia's national immunization program and the post-introduction assessment of the human papillomavirus (HPV) vaccine were presented.
Following amendments to the Law on Immunization in 2023, Mongolia included vaccines against hepatitis A, pneumococcal disease, and human papillomavirus (HPV) infection in its mandatory immunization program. In line with these amendments, the Government approved a revised National Immunization Schedule under Resolution No. 472 of 2023. As of today, children in Mongolia receive nine types of vaccines protecting against 13 infectious diseases from birth to the age of 15.
Under the revised schedule, Mongolia introduced HPV vaccination nationwide in 2024 and began immunizing 11-year-old children regardless of sex. The World Health Organization (WHO) recommends that countries conduct a post-introduction evaluation after introducing a new vaccine. In accordance with this recommendation, Mongolia carried out a post-introduction evaluation of the HPV vaccine alongside the broader evaluation of its national immunization program in May 2026.
As part of the preparatory work, online briefing sessions for relevant
organizations were held on May 18–20, 2026. Field evaluations were then
conducted from May 22 to 27 at the national level, as well as in four selected
aimags, two districts, and two maternity hospitals. The evaluation was carried
out jointly with independent assessment teams from the WHO and UNICEF.
During a meeting to present the preliminary findings, key results and recommendations from the evaluation were introduced. Representatives of relevant organizations exchanged views and discussed follow-up measures, according to the Ministry of Health.
